Toxicological assessment of isomeric pesticides: a strategy for testing of chiral organophosphorus (OP) compounds for delayed polyneuropathy in a regulatory setting.
Many compounds, including some pesticides, contain structural centres of asymmetry, which convey the property of a type of stereoisomerism known as chirality. Such compounds can exist in two or more forms, depending on the number of chiral atoms and are termed stereoisomers or enantiomers. Stereoisomers of a particular compound can have different biological properties; one such of particular importance for toxicological evaluation, is the potential for differences in metabolic disposal of and binding of stereoisomers to molecular targets in the cell. The combination of differential metabolism of chiral organophosphorus (OP) pesticides and opposing stereoselectivity of inhibition of neuropathy target esterase (NTE) and acetylcholinesterase (AChE) can affect the value of the hen test, performed to OECD guidelines, in predicting the potential to cause organophosphate-induced delayed polyneuropathy (OPIDP) in humans. This is a mixed central and sensory and motor neuropathy. The experimental data on structural analogues of the pesticide methamidophos and the evidence for stereoselective OPIDP are reviewed and a model is given demonstrating how the properties of a chiral OP can result in the neuropathic potential not being detected by the standard hen test. A strategy for the assessment of a racemic mixture comprised of two OP enantiomers for the potential to induce OPIDP is outlined. The strategy uses information from structure activity relationships (SAR), in vitro tests and in vivo tests to allow risk assessment decisions to be made. It is suggested that the potential for stereoselective toxicity of pesticides should be routinely considered in regulatory assessments.
Battershill
Jon M
JM
Department of Health, Skipton House, 80 London Road, London SE1 6LH, UK.
Edwards
Philippa M
PM
Johnson
Martin K
MK
D000818:Animals; D002800:Cholinesterase Inhibitors / Q000633:toxicity; D004791:Enzyme Inhibitors / Q000633:toxicity; D007536:Isomerism; D009943:Organophosphorus Compounds / Q000737:chemistry* / Q000633:toxicity*; D010575:Pesticides / Q000737:chemistry* / Q000633:toxicity*; D011115:Polyneuropathies / Q000139:chemically induced* / Q000473:pathology*; D011237:Predictive Value of Tests; D013237:Stereoisomerism; D014116:Toxicology / Q000331:legislation & jurisprudence* / Q000379:methods*
D002800:Cholinesterase Inhibitors; D004791:Enzyme Inhibitors; D009943:Organophosphorus Compounds; D010575:Pesticides